Global NGS-Based Monitoring and Diagnostic Test Market Research Report 2024
Published on: 2024-01-04 | No of Pages : 400 | Industry : Latest Trends
Publisher : MRA | Format : PDF
Global NGS-Based Monitoring and Diagnostic Test Market Research Report 2024
NGS-Based Monitoring and Diagnostic Test is based on the NGS, aiming for the monitoring and diagnostic test. Next generation sequencing (NGS), massively parallel or deep sequencing are related terms that describe a DNA sequencing technology which has revolutionised genomic research. Using NGS an entire human genome can be sequenced within a single day.
According to MRA Research’s new survey, global NGS-Based Monitoring and Diagnostic Test market is projected to reach US$ million in 2033, increasing from US$ million in 2023, with the CAGR of % during the period of 2023 to 2033. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole NGS-Based Monitoring and Diagnostic Test market research.
Key companies engaged in the NGS-Based Monitoring and Diagnostic Test industry include Agilent Technologies, Inc., Ancestry.com LLC, ArcherDX, Inc., Beijing Genomics Institute (BGI), Cancer Genetics, Inc., CENTOGENE AG, F. Hoffmann-La Roche Ltd, GenePath Dx and Illumina, Inc., etc. Among those companies, the top 3 players guaranteed % supply worldwide in 2023.
When refers to consumption region, % value of NGS-Based Monitoring and Diagnostic Test were sold to North America, Europe and Asia Pacific in 2023. Moreover, China, plays a key role in the whole NGS-Based Monitoring and Diagnostic Test market and estimated to attract more attentions from industry insiders and investors.
Report Scope
This report, based on historical analysis (2018-2023) and forecast calculation (2023-2033), aims to help readers to get a comprehensive understanding of global NGS-Based Monitoring and Diagnostic Test market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
![](http//localhost/mraccuracy/images/Market%20Recearch%20Graph.jpg)
Agilent Technologies, Inc.
Ancestry.com LLC
ArcherDX, Inc.
Beijing Genomics Institute (BGI)
Cancer Genetics, Inc.
CENTOGENE AG
F. Hoffmann-La Roche Ltd
GenePath Dx
Illumina, Inc.
Laboratory Corporation of America Holdings
Myriad Genetics, Inc.
QIAGEN N.V.
Quest Diagnostics Incorporated
Siemens Healthineers, Inc.
Thermo Fisher Scientific Inc.
HTG Molecular Diagnostics, Inc.
Vela Diagnostics Pte. Ltd.
Segment by Type
Commercial Assays/Tests
Laboratory Developed Tests
Direct to Consumer Test
Pre-Commercial Tests
Out-Patient Clinics/General Practitioners
Diagnostic Centers
Hospitals
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
The NGS-Based Monitoring and Diagnostic Test report covers below items
Chapter 1Product Basic Information (Definition, Type and Application)
Chapter 2Global market size, regional market size. Market Opportunities and Challenges
Chapter 3Companies’ Competition Patterns
Chapter 4Product Type Analysis
Chapter 5Product Application Analysis
Chapter 6 to 10Country Level Value Analysis
Chapter 11Companies' Outline
Chapter 12Market Conclusions
Chapter 13Research Methodology and Data Source![](http://localhost/mraccuracy/images/About Report.webp)
According to MRA Research’s new survey, global NGS-Based Monitoring and Diagnostic Test market is projected to reach US$ million in 2033, increasing from US$ million in 2023, with the CAGR of % during the period of 2023 to 2033. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole NGS-Based Monitoring and Diagnostic Test market research.
Key companies engaged in the NGS-Based Monitoring and Diagnostic Test industry include Agilent Technologies, Inc., Ancestry.com LLC, ArcherDX, Inc., Beijing Genomics Institute (BGI), Cancer Genetics, Inc., CENTOGENE AG, F. Hoffmann-La Roche Ltd, GenePath Dx and Illumina, Inc., etc. Among those companies, the top 3 players guaranteed % supply worldwide in 2023.
When refers to consumption region, % value of NGS-Based Monitoring and Diagnostic Test were sold to North America, Europe and Asia Pacific in 2023. Moreover, China, plays a key role in the whole NGS-Based Monitoring and Diagnostic Test market and estimated to attract more attentions from industry insiders and investors.
Report Scope
This report, based on historical analysis (2018-2023) and forecast calculation (2023-2033), aims to help readers to get a comprehensive understanding of global NGS-Based Monitoring and Diagnostic Test market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
![](http//localhost/mraccuracy/images/Market%20Recearch%20Graph.jpg)
By Company
Agilent Technologies, Inc.
Ancestry.com LLC
ArcherDX, Inc.
Beijing Genomics Institute (BGI)
Cancer Genetics, Inc.
CENTOGENE AG
F. Hoffmann-La Roche Ltd
GenePath Dx
Illumina, Inc.
Laboratory Corporation of America Holdings
Myriad Genetics, Inc.
QIAGEN N.V.
Quest Diagnostics Incorporated
Siemens Healthineers, Inc.
Thermo Fisher Scientific Inc.
HTG Molecular Diagnostics, Inc.
Vela Diagnostics Pte. Ltd.
Segment by Type
Commercial Assays/Tests
Laboratory Developed Tests
Direct to Consumer Test
Pre-Commercial Tests
Segment by Application
Out-Patient Clinics/General Practitioners
Diagnostic Centers
Hospitals
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
The NGS-Based Monitoring and Diagnostic Test report covers below items
Chapter 1Product Basic Information (Definition, Type and Application)
Chapter 2Global market size, regional market size. Market Opportunities and Challenges
Chapter 3Companies’ Competition Patterns
Chapter 4Product Type Analysis
Chapter 5Product Application Analysis
Chapter 6 to 10Country Level Value Analysis
Chapter 11Companies' Outline
Chapter 12Market Conclusions
Chapter 13Research Methodology and Data Source
![](http://localhost/mraccuracy/images/About Report.webp)